Location: Home
  • search
  • go
  • Relate News
  • 11/26/2018NHC: HIV/AIDS Rate at Low Level in China
  • 11/26/2018Chi-Med and Eli Lilly Announce First Commercial Launch of Fruquintinib...
  • 11/23/2018Recent Executive Moves
  • 11/23/2018MOFCOM Solicits Comments on Draft Guidelines for National Classificati...
  • 11/23/2018National Pharmacopoeia Commission Solicits Comments on Guide for Gener...
  • 11/22/2018CDE Solicits Comments on Guideline for Clinical Research of Age-Relate...
  • 11/22/2018Trump Administration Accuses China of Unfairly Using Venture Capital t...
  • 11/22/2018HitGen and Biogen enter a DNA-Encoded Library-Based Drug Discovery Res...
  • 11/20/2018Ascletis and Roche Enter Exclusive Pegasys Partnership in China for Vi...
  • 11/20/2018Sanofi China to Open New $114M Research Site in Suzhou
  • 11/20/2018NMPA Issues Notice for Implementation of State Council’s “Permit and...
  • 11/20/2018Alphamab raises $100M in Series A financing from US, Asian investors
  • 11/19/2018Huadong Medicine Completes Acquisition of U.K.'s Sinclair Pharma
  • 11/19/2018CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi
  • 11/19/2018CCDRC Approves Plan for National Centralized Drug Purchase Trial
  • 11/19/2018NH Reports on Chinese OTC Eye Care Market in MAT 09/2018
  • 11/19/2018Eli Lilly Mulls Sale of Certain Off-patent CNS and Antibiotic Assets i...
  • 11/16/2018NMPA Approves Gilead's Vemlidy (Tenofovir Alafenamide) in China
  • 11/16/2018Chi-Med Announces Negative Results of Phase III Chinese Trial for Fruq...
  • 11/16/2018NMPA Grants Priority Review to BeiGene's NDAs for Zanubrutinib and Tis...
  • 11/15/2018How China Will Handle Its Trade War With the United States in 2019
  • 11/15/2018MorphoSys and I-Mab Enter Strategic Alliance for MorphoSys's Novel I/O...
  • 11/15/2018Catalent Invests in Its 2nd Clinical Supply Facility in Shanghai
  • 11/15/2018President Xi Pledges to Protect IP and Boost Import at 1st Import Expo
  • 11/14/2018U.S. Trade Union Urges USFDA to Investigate GNC Acquisition by Harbin ...
  • 11/13/2018CFIUS Broadens Coverage of Cross-Border Biotech Transactions
  • 11/13/2018China's Crackdown on Genetics Breaches Could Deter Data Sharing
  • 11/13/2018NMPA Issues Rules for Drug Export Sales Certificate
  • 11/12/2018Angion Biomedica and Sinovant Enter Licensing Deal to Develop AKI Drug...
  • 11/12/2018Yifan Subsidiary Announces Chinese IND Approval of Anticaner A-319
  • Page:303/775 Total number of articles:23233: [First][<<] [301] [302] [303] [304] [305] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group